SAN DIEGO, Aug. 25 /PRNewswire-FirstCall/ -- CareFusion Corporation announced today that its stock will be included in the S&P 500 index following the company's planned spinoff from Cardinal Health on Aug. 31. CareFusion stock will be added to the index on Sept. 1, coinciding with its first day of regular-way trading on the New York Stock Exchange under the symbol "CFN." "Our inclusion in the S&P 500 is a testament to our position in the industry as we launch a new public company dedicated to helping hospitals improve patient care and safety, both domestically and around the world," said David Schlotterbeck, chief executive officer of CareFusion. "We are pleased to be recognized among such a select group of U.S. companies." CareFusion provides products and services designed to help measurably improve patient care in two major areas: medication errors and hospital-acquired infections. The company's common stock began trading on a "when issued" basis on Aug. 21. On Aug. 31, "when issued" trading is scheduled to end and "regular way" trading is scheduled to begin on Sept. 1 under the ticker symbol "CFN." Regarded as one of the best single gauges of the U.S. equities market, the S&P 500 index includes 500 leading companies in leading industries of the U.S. economy. About CareFusion Corporation CareFusion Corporation is currently a wholly owned subsidiary of Cardinal Health (NYSE:CAH). The global company serves the health care industry with products and services that help hospitals measurably improve the safety and quality of care. CareFusion develops market-leading technologies including Alaris IV pumps, Pyxis automated dispensing and patient identification systems, AVEA and Pulmonetic Systems(TM) ventilation and respiratory products, ChloraPrep for infection prevention and MedMined(TM) services for infection surveillance, neurological monitoring and diagnostic products, V. Mueller surgical instruments and an extensive line of products that support interventional medicine. CareFusion employs more than 15,000 people across its global operations. The company has been authorized to have its shares of common stock listed on the New York Stock Exchange under the ticker symbol "CFN." More information may be found at carefusion.com. Cautions concerning forward-looking statements This news release contains forward-looking statements addressing the planned spinoff of the clinical and medical products businesses of Cardinal Health as a separate company named CareFusion Corporation, which is dependent upon future events or developments. These matters are subject to risks and uncertainties that could cause actual events (including the planned spinoff) and results to differ materially from those projected, anticipated or implied. These risks and uncertainties include uncertainties regarding the planned spinoff of CareFusion, including the timing and terms of such spinoff and whether such spinoff will be completed as it is subject to a number of conditions. In addition, Cardinal Health and CareFusion are subject to additional risks and uncertainties described in CareFusion's Form 10, as amended, and Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports (including all amendments to those reports) and exhibits to those filings and reports. Except to the extent required by applicable law, Cardinal Health and CareFusion undertake no obligation to update or revise any forward-looking statement. DATASOURCE: CareFusion Corporation CONTACT: Media, Jim Mazzola, +1-858-617-1203, ; or Investors, Carol Cox, +1-858-617-2020, , both of CareFusion Corporation Web Site: http://www.carefusion.com/

Copyright